This study investigates the regulation of parkinsonian motor behaviors through optogenetic control of basal ganglia circuitry. Researchers used optogenetics to selectively activate direct and indirect pathways in the striatum of mice, revealing their distinct roles in motor behavior. Activation of direct-pathway medium spiny projection neurons (MSNs) reduced freezing and increased locomotion, while activation of indirect-pathway MSNs induced a parkinsonian state characterized by increased freezing, bradykinesia, and decreased locomotion. In a mouse model of Parkinson's disease, direct-pathway activation completely rescued deficits in freezing, bradykinesia, and locomotor initiation. These findings support the classical model of basal ganglia function, where the direct pathway facilitates movement and the indirect pathway inhibits it. The study also demonstrates that optogenetic activation of direct-pathway circuits can ameliorate parkinsonian motor deficits, suggesting a potential therapeutic strategy for Parkinson's disease. The research highlights the critical role of basal ganglia circuitry in the bidirectional regulation of motor behavior and provides insights into the functional organization of these circuits. The study used a combination of optogenetic techniques, electrophysiology, and behavioral analysis to investigate the effects of activating direct and indirect pathways in the striatum. The results indicate that direct-pathway activation can restore motor function in Parkinson's disease models, offering new avenues for therapeutic intervention.This study investigates the regulation of parkinsonian motor behaviors through optogenetic control of basal ganglia circuitry. Researchers used optogenetics to selectively activate direct and indirect pathways in the striatum of mice, revealing their distinct roles in motor behavior. Activation of direct-pathway medium spiny projection neurons (MSNs) reduced freezing and increased locomotion, while activation of indirect-pathway MSNs induced a parkinsonian state characterized by increased freezing, bradykinesia, and decreased locomotion. In a mouse model of Parkinson's disease, direct-pathway activation completely rescued deficits in freezing, bradykinesia, and locomotor initiation. These findings support the classical model of basal ganglia function, where the direct pathway facilitates movement and the indirect pathway inhibits it. The study also demonstrates that optogenetic activation of direct-pathway circuits can ameliorate parkinsonian motor deficits, suggesting a potential therapeutic strategy for Parkinson's disease. The research highlights the critical role of basal ganglia circuitry in the bidirectional regulation of motor behavior and provides insights into the functional organization of these circuits. The study used a combination of optogenetic techniques, electrophysiology, and behavioral analysis to investigate the effects of activating direct and indirect pathways in the striatum. The results indicate that direct-pathway activation can restore motor function in Parkinson's disease models, offering new avenues for therapeutic intervention.